Helping Clients Assess Market Potential, Identify High-Value Opportunities, and Make Confident Investment Decisions
In today’s dynamic healthcare and life sciences ecosystem, understanding a market’s true size and long-term growth path is crucial. DelveInsight’s Market Size & Forecast Assessment empowers organizations with precise, data-backed estimations, actionable intelligence, and reliable projections to guide strategic planning and investment decisions.
? Discover how our assessments drive smarter decisions:
https://www.delveinsight.com/case-study/market-size-forecast-assessment?utm_source=casestudy&utm_medium=promotion&utm_campaign=mpr
Client Challenge
A leading global biopharmaceutical company needed to evaluate the commercial potential of an upcoming therapy in a highly competitive field. The client sought a robust, multi-geography market size assessment segmented by disease types, treatment lines, and patient demographics. However, publicly available data was inconsistent and fragmented, making it difficult to validate epidemiology estimates, competitor shares, and emerging opportunity areas. They required a reliable forecasting framework to support portfolio strategy, resource allocation, and long-term business planning.
Our Approach
To address this challenge, DelveInsight deployed a comprehensive analytical framework combining primary insights, secondary data, epidemiology modeling, and advanced market analytics to deliver a precise, validated forecast.
1. Objective
The goal of this engagement was to help a European-based medical-device company evaluate the commercial potential of entering the Patent Foramen Ovale (PFO) closure-device market in the European Union. The client sought clarity on patient pools, device market size, competitive presence, and reimbursement pathways to support their business development and market-entry strategy.
2. Problem Statement
The client encountered several strategic hurdles:
Limited clarity on the total treatable PFO patient pool across indications such as cryptogenic stroke, migraine, and decompression sickness, hindering accurate market sizing.
Uncertainty around pricing, treatment trends, procedure volumes, and device adoption patterns across EU regions.
An opaque competitive landscape with insufficient visibility into current device players, market shares, and country-level splits.
Limited understanding of reimbursement frameworks necessary for informed pricing, access planning, and launch readiness.
? Explore how DelveInsight solves complex commercial challenges:
https://www.delveinsight.com/case-study/market-size-forecast-assessment?utm_source=casestudy&utm_medium=promotion&utm_campaign=mpr
3. Our Methodology
DelveInsight utilized a rigorous, multi-step, data-driven approach:
Patient-Pool & Epidemiology Modeling:
We quantified at-risk populations across key indications and narrowed them to the treatable PFO patient pool by country and segment.
Treatment-Practice & Adoption Analysis:
We evaluated current care pathways, procedural trends, device usage, and market penetration levels across major EU markets to establish realistic baseline dynamics.
Device Pricing & Procedure Economics:
We conducted detailed assessments of device costs, procedure pricing, utilization rates, and regional adoption to build accurate revenue-per-patient models.
Market Size & Forecasting Framework:
By integrating epidemiology inputs, treatment patterns, pricing, and competitive metrics, we built a segmented forecast model projecting market size by country, indication, and product type.
Competitive Landscape Mapping:
We analyzed existing competitors, their shares, positioning, and market dynamics. Key drivers, barriers, and growth catalysts—including reimbursement changes—were also assessed.
? See our complete methodology in action:
https://www.delveinsight.com/case-study/market-size-forecast-assessment?utm_source=casestudy&utm_medium=promotion&utm_campaign=mpr
4. Results
DelveInsight delivered a comprehensive market-entry blueprint, including:
Current and projected market size for PFO devices across EU countries
Detailed addressable market estimates and revenue forecasts by segment
Insights into high-opportunity patient groups and priority geographies
Competitive share mapping with clear differentiation strategies
Reimbursement environment analysis informing access and pricing pathways
Armed with these insights, the client was able to:
Prioritize the most commercially attractive markets
Strengthen product positioning in relation to existing players
Anticipate competitive pricing strategies
Develop an optimized launch, sales, and marketing roadmap
Minimize risk in market-entry planning and resource allocation
Why Partner with DelveInsight?
With deep epidemiology expertise, therapeutic domain knowledge, and strong analytical capabilities, DelveInsight serves as a trusted intelligence partner for global pharma and medtech companies. Our forecasts are transparent, evidence-backed, customizable, and geared toward enabling strategic clarity in complex markets.
Conclusion
This case study highlights how a robust market size and forecasting assessment can convert uncertainty into actionable strategy. By understanding patient pools, treatment dynamics, pricing structures, and competitive landscapes, organizations can confidently plan market entry, optimize resources, and drive sustainable commercial success.
